-
May 20, 2025 Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers
-
May 15, 2025 Punita Lal Joins Lupin Board as Additional Director
-
May 15, 2025 Lupin Receives Approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
-
May 14, 2025 Lupin FY2025 Results
-
May 13, 2025 Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity
-
May 8, 2025 Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg
-
May 7, 2025 Lupin Launches Eslicarbazepine Acetate Tablets in the United States
-
April 24, 2025 Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets
-
April 23, 2025 Lupin Diagnostics Achieves NABL Accreditation for All Greenfield Labs
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications